Activist investors have been busy as of late. One example of this activity involves Nelson Peltz’s Trian Fund Management resuming its...

According to Financial Times, US, New York-listed, biotech company, Illumina, is being ordered by EU regulators to sell cancer test...

Activist investing has been on the rise since 2017 – with numerous, high-profile cases grabbing headlines. As this investment strategy...